ABRAXANE in Danish translation

• ABRAXANE

Examples of using Abraxane in English and their translations into Danish

The Committee decided that Abraxane' s benefits are greater than its risks for the treatment of metastatic breast cancer in patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline-containing therapy is not indicated.
Udvalget konkluderede, at fordelene ved Abraxane opvejede risiciene ved behandling af metastatisk brystkræft hos patienter, for hvem førstevalgsbehandlingen ikke længere virkede, og for hvem behandling med en antracyklin ikke er mulig.

severe sensory neuropathy during Abraxane therapy should have the dose reduced to 220 mg/ m2 for subsequent courses.
svær sensorisk neuropati under behandling med Abraxane, bør have doseringen reduceret til 220 mg/ m2 i efterfølgende behandlinger.

HOW TO STORE ABRAXANE.
Sådan opbevarer de/ du abraxane.

What is the risk associated with Abraxane?
Hvilken risiko er der forbundet med Abraxane?

Adverse reactions reported with Abraxane at any dose in clinical trials.
Bivirkninger rapporteret med Abraxane i forskellige doser i kliniske forsøg.

Abraxane should not be used in combination with other anticancer agents.
Abraxane bør ikke anvendes sammen med andre kræftbehandlingsmidler.

Alopecia was observed in 90% of the patients treated with Abraxane.
Hårtab blev observeret hos 90% af patienterne, som blev behandlet med Abraxane.

Abraxane is supplied as a sterile lyophilised powder for reconstitution before use.
Abraxane leveres som et sterilt, frysetørret pulver til rekonstitution inden brugen.

The protein binding of paclitaxel following Abraxane administration is estimated at about 90.
Proteinbindingen for paclitaxel efter Abraxane indgift er estimeret til omkring 90.

Abraxane may have substantially different pharmacological properties compared to other paclitaxel formulations.
Abraxane kan have væsentligt forskellige farmakologiske egenskaber sammenlignet med andre paclitaxel- formuleringer.

Abraxane is a medicine containing paclitaxel in human albumin portion of blood.
Abraxane er et lægemiddel, der indeholder paclitaxel i humant albumin indgår i blodet.

Like all medicines, Abraxane can cause side-effects,
Abraxane kan som al anden medicin give bivirkninger,

Because of potential serious adverse reactions in breast-feeding infants, Abraxane is contraindicated during lactation.
På grund af potentielle alvorlige bivirkninger for diende spædbørn, er Abraxane kontraindiceret under amning.

If Abraxane contacts mucous membranes,
Hvis Abraxane kommer i kontakt med slimhinder,

Abraxane should not be used in patients who have severe problems with their liver.
Abraxane bør ikke anvendes til patienter, der har alvorlige leverproblemer.

The use of Abraxane has not been formally studied in patients specifically with hepatic impairment.
Anvendelsen af Abraxane er ikke undersøgt specielt hos patienter med nedsat leverfunktion.

Patients treated with Abraxane in the randomized, controlled clinical trial were evaluated for safety.
Patienter, der blev behandlet med Abraxane i det randomiserede, kontrollerede kliniske forsøg blev evalueret med hensyn til sikkerhed.

Abraxane should not be administered until neutrophil counts recover to> 1.5 x 109/ l.
Abraxane bør ikke administreres før neutrofiltallet atter er> 1, 5 x 109/ l.

severity of neurotoxicity was dose-dependent in patients receiving Abraxane.
sværhedsgraden af neurotoksicitet dosisafhængig hos patienter, der fik Abraxane.

The effects of Abraxane were first tested in experimental models before being studied in humans.
Virkningerne af Abraxane blev først afprøvet i forsøgsmodeller, inden de blev undersøgt hos mennesker.